SCA Pharmaceuticals Recalls Glycopyrrolate Injection Due to Labeling Error
SCA Pharmaceuticals is recalling 972 syringes of Glycopyrrolate injection distributed in Louisiana because a printing error made the expiration date appear incorrect.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text identifies the issue as a minor labeling error (printing overlap) without reporting any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
SCA Pharmaceuticals is voluntarily recalling 972 syringes of Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syringe. The affected product was distributed in Louisiana. The recall involves two specific lots: 20141218@41 with a use-by date of 3/18/2015, and 20141226@24 with a use-by date of 3/26/2015.
The recall was initiated due to a labeling defect. A printing error caused the characters "y" and "3" to overlap, making the actual "Use By 3/2015" date appear to read "Use By 8/2015". This discrepancy could lead to the use of expired medication.
Consumers and healthcare providers who have this product should stop using it and contact SCA Pharmaceuticals at 877-550-5059 for further instructions. The product is prescription-only.
The recalled product
- Product
- Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syringe, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, 877-550-5059
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Injection
- Hazard
- Affected units
- 972
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 20141218@41
- Use by 3/18/2015
- 20141226@24
- Use by 3/26/2015
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02